Top journals
Frequent coauthors
- Cohen A 6
- Recker RR 3
- Dempster DW 3
- Zhou H 3
- Cremers S 2
- Nickolas TL 2
- Stubby J 2
- Lappe JM 2
- Fratzl-Zelman N 1
- Bucovsky M 1
ContextWithout antiresorptive therapy, postmenopausal women lose bone mass after teriparatide (TPTD) discontinuation; estrogen treatment prevents bone loss in this setting. It is not known whether premenopausal women with regular menses los…
Bone mineralization density distribution (BMDD) is an important determinant of bone mechanical properties. The most available skeletal site for access to the BMDD is the iliac crest. Compared to cancellous bone much less information on BMDD…
Interpretation of bone mineral density (BMD) results in premenopausal women is particularly challenging, since the relationship between BMD and fracture risk is not the same as for postmenopausal women. In most cases, Z scores rather than T…
This article will discuss the diagnosis of osteoporosis in premenopausal women and the evaluation and management of those with low-trauma fractures and/or low bone mineral density. As secondary causes (glucocorticoid excess, anorexia nervos…
ContextPremenopausal women with idiopathic osteoporosis (IOP) have abnormal cortical and trabecular bone microarchitecture.ObjectiveThe purpose of this study was to test the hypotheses that teriparatide increases bone mineral density (BMD) …
Interpretation of bone mineral density (BMD) results in premenopausal women is particularly challenging, because the relationship between BMD and fracture risk is not the same as for postmenopausal women. Z scores rather than T scores shoul…